From: Feasibility of up-regulating CD4+CD25+ Tregs by IFN-γ in myasthenia gravis patients
IFN-γ (ng/ml)
0
20
40
80
CD4+CD25+ (%)
18.3 ± 4.1**
29.2 ± 3.1*,**
43.1 ± 3.7*
32.3 ± 4.5*,**